Proton NMR analysis of plasma is a weak predictor of coronary artery disease. (Q48547379)

12 February 2018

title

Proton NMR analysis of plasma is a weak predictor of coronary artery disease. (English)

1 reference

12 February 2018

author name string

Heide L Kirschenlohr

1

1 reference

12 February 2018

Julian L Griffin

2

1 reference

12 February 2018

Sarah C Clarke

3

1 reference

12 February 2018

Ranyl Rhydwen

4

1 reference

12 February 2018

Andrew A Grace

5

1 reference

12 February 2018

Peter M Schofield

6

1 reference

12 February 2018

Kevin M Brindle

7

1 reference

12 February 2018

James C Metcalfe

8

1 reference

12 February 2018

language of work or name

English

0 references

publication date

28 May 2006

1 reference

12 February 2018

published in

Nature Medicine

1 reference

12 February 2018

volume

12

1 reference

12 February 2018

issue

6

1 reference

12 February 2018

page(s)

705-710

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/nm1432

exact match

0 references

cites work

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

1 reference

Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension

21 January 2018

1 reference

Lipoprotein abnormalities related to women's health

21 January 2018

1 reference

Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy

21 January 2018

1 reference

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland

21 January 2018

1 reference

Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

21 January 2018

1 reference

Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women

21 January 2018

1 reference

Bias as a threat to the validity of cancer molecular-marker research

21 January 2018

1 reference

1H NMR studies of human blood plasma. Assignment of resonances for lipoproteins.

21 January 2018

1 reference

Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients

21 January 2018

1 reference

MR spectroscopy quantitation: a review of frequency domain methods

21 January 2018

1 reference

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

21 January 2018

1 reference

Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis

21 January 2018

1 reference

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse

21 January 2018

1 reference

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

7 January 2021

Effects of orientational order and particle size on the NMR line positions of lipoproteins

1 reference

7 January 2021

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

7 January 2021

Accurate quantification ofin vivo31P NMR signals using the variable projection method and prior knowledge

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1432

1 reference

12 February 2018

release_tj5gm3qih5dlvlbq4r45wsytp4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tj5gm3qih5dlvlbq4r45wsytp4

24 November 2022

mapped directly with Wikidata item

PubMed ID

16732278

1 reference

12 February 2018